Versigent
VGNT | NYSE
$40.95
-$0.11 (-0.27%)
Nov 2, 2026, 3:58 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q4 2024 Dec 31, 2024 |
|---|---|---|---|---|---|
Cash & Equivalents | 554M | 282M | 763M | 234M | 201M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 149M | 179M | 143M | 146M | 132M |
Other Long-Term Assets | 128M | 97M | 118M | 115M | 101M |
Receivables | 2.08B | 1.96B | 1.68B | 1.77B | 1.51B |
Inventory | 772M | 792M | 772M | 795M | 709M |
Other Current Assets | 100M | 83M | 14M | 15M | 9M |
Total Current Assets | 3.54B | 3.15B | 3.26B | 2.84B | 2.44B |
Property-Plant & Equipment | 1.09B | 1.08B | 1.08B | 1.04B | 1.08B |
Goodwill & Intangibles | 6M | 7M | 7M | 8M | 7M |
Total Long-Term Assets | 1.82B | 1.76B | 1.74B | 1.66B | 1.7B |
Total Assets | 5.36B | 4.91B | 5B | 4.5B | 4.14B |
Account Payables | 1.67B | 1.36B | 1.53B | 1.46B | 1.33B |
Deferred Revenue | 29M | n/a | n/a | n/a | 35M |
Short-Term Debt | 153M | 118M | 58M | 15M | 229M |
Other Current Liabilities | 128M | 433M | n/a | n/a | 170M |
Total Current Liabilities | 2.53B | 2.28B | 2.18B | 2.1B | 2.1B |
Long-Term Debt | 2.07B | 2.07B | 499M | 3M | 4M |
Other Long-Term Liabilities | 278M | 250M | 309M | 319M | 160M |
Total Long-Term Liabilities | 2.54B | 2.49B | 978M | 452M | 323M |
Total Liabilities | 5.08B | 4.77B | 3.16B | 2.55B | 2.42B |
Total Debt | 2.42B | 2.33B | 698M | 148M | 419M |
Book Value | 284M | 143M | 1.84B | 1.95B | 1.72B |
Book Value Per Share | 3.95 | 2.02 | 25.91 | 27.49 | 24.24 |
Common Stock | 1M | n/a | n/a | n/a | n/a |
Retained Earnings | 118M | n/a | n/a | n/a | n/a |
Comprehensive Income | -177M | -48M | -268M | -289M | -341M |
Shareholders Equity | 85M | -48M | 1.65B | 1.77B | 1.52B |
Total Investments | 149M | 179M | 143M | 146M | 132M |
Add to Watchlist
Select watchlists to add or remove VGNT